{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:13Z","timestamp":1760853733294},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T00:00:00Z","timestamp":1378771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12031-013-0103-8","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T01:13:56Z","timestamp":1378689236000},"page":"1-9","source":"Crossref","is-referenced-by-count":25,"title":["NAP Alpha-Aminoisobutyric Acid (IsoNAP)"],"prefix":"10.1007","volume":"52","author":[{"given":"Illana","family":"Gozes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulie","family":"Schirer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Idan-Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Furman-Assaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,10]]},"reference":[{"key":"103_CR1","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.peptides.2003.08.005","volume":"24","author":"O Ashur-Fabian","year":"2003","unstructured":"Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E, Gozes I (2003) The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides 24:1413\u20131423","journal-title":"Peptides"},{"key":"103_CR2","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","volume":"72","author":"M Bassan","year":"1999","unstructured":"Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, Bassan H, Blat C, Gibney G, Glazner G, Brenneman DE, Gozes I (1999) Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 72:1283\u20131293","journal-title":"J Neurochem"},{"key":"103_CR3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbr.2008.05.008","volume":"193","author":"A Bour","year":"2008","unstructured":"Bour A, Grootendorst J, Vogel E, Kelche C, Dodart JC, Bales K, Moreau PH, Sullivan PM, Mathis C (2008) Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav Brain Res 193:174\u2013182","journal-title":"Behav Brain Res"},{"key":"103_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00207458909002151","volume":"48","author":"R Brandeis","year":"1989","unstructured":"Brandeis R, Brandys Y, Yehuda S (1989) The use of the Morris water maze in the study of memory and learning. Int J Neurosci 48:29\u201369","journal-title":"Int J Neurosci"},{"key":"103_CR5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1124\/jpet.103.063891","volume":"309","author":"DE Brenneman","year":"2004","unstructured":"Brenneman DE, Spong CY, Hauser JM, Abebe D, Pinhasov A, Golian T, Gozes I (2004) Protective peptides that are orally active and mechanistically nonchiral. J Pharmacol Exp Ther 309:1190\u20131197","journal-title":"J Pharmacol Exp Ther"},{"key":"103_CR6","doi-asserted-by":"crossref","first-page":"28531","DOI":"10.1074\/jbc.M403197200","volume":"279","author":"I Divinski","year":"2004","unstructured":"Divinski I, Mittelman L, Gozes I (2004) A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J Biol Chem 279:28531\u201328538","journal-title":"J Biol Chem"},{"key":"103_CR7","doi-asserted-by":"crossref","first-page":"10223","DOI":"10.1021\/bi980537d","volume":"37","author":"P Friedhoff","year":"1998","unstructured":"Friedhoff P, Schneider A, Mandelkow EM, Mandelkow E (1998) Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 37:10223\u201310230","journal-title":"Biochemistry"},{"key":"103_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2004.09.077","volume":"373","author":"S Furman","year":"2005","unstructured":"Furman S, Hill JM, Vulih I, Zaltzman R, Hauser JM, Brenneman DE, Gozes I (2005) Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus. Neurosci Lett 373:73\u201378","journal-title":"Neurosci Lett"},{"key":"103_CR9","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1002\/anie.200353565","volume":"43","author":"S Gilead","year":"2004","unstructured":"Gilead S, Gazit E (2004) Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid. Angew Chem Int Ed Engl 43:4041\u20134044","journal-title":"Angew Chem Int Ed Engl"},{"key":"103_CR10","first-page":"85","volume":"8","author":"M Gold","year":"2012","unstructured":"Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I (2012) Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. Neuropsychiatr Dis Treat 8:85\u201393","journal-title":"Neuropsychiatr Dis Treat"},{"key":"103_CR11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1039\/9781849731072-00108","volume-title":"Emerging drugs and targets for Alzheimer\u2019s disease","author":"I Gozes","year":"2010","unstructured":"Gozes I (2010) Davunetide (NAP) pharmacology: neuroprotection and tau. In: Martinez A (ed) Emerging drugs and targets for Alzheimer\u2019s disease, vol 3. Royal Society of Chemistry, Cambridge, pp 108\u2013128"},{"key":"103_CR12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/138161211795589373","volume":"17","author":"I Gozes","year":"2011","unstructured":"Gozes I (2011) NAP (davunetide) provides functional and structural neuroprotection. Curr Pharm Des 17:1040\u20131044","journal-title":"Curr Pharm Des"},{"key":"103_CR13","doi-asserted-by":"crossref","unstructured":"Gozes I, Baas PW (2013) Activity-dependent neuroprotective protein (ADNP) and davunetide (NAP). In: Kastin AJ (ed) Handbook of biologically active peptide (Illana Gozes editor of section XVIII, pp 1611\u20131653), 2nd edn. Academic Press, New York, pp 1611\u20131618","DOI":"10.1016\/B978-0-12-385095-9.00220-7"},{"issue":"Suppl 3","key":"103_CR14","first-page":"S3","volume":"9","author":"I Gozes","year":"2008","unstructured":"Gozes I, Divinski I, Piltzer I (2008) NAP and d-SAL: neuroprotection against beta amyloid peptide (1\u201342). Curr Alzheimer Res 9(Suppl 3):S3","journal-title":"Curr Alzheimer Res"},{"key":"103_CR15","first-page":"1091","volume":"293","author":"I Gozes","year":"2000","unstructured":"Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE (2000) Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharmacol Exp Ther 293:1091\u20131098","journal-title":"J Pharmacol Exp Ther"},{"key":"103_CR16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1527-3458.2005.tb00053.x","volume":"11","author":"I Gozes","year":"2005","unstructured":"Gozes I, Morimoto BH, Tiong J, Fox A, Sutherland K, Dangoor D, Holser-Cochav M, Vered K, Newton P, Aisen PS, Matsuoka Y, van Dyck CH, Thal L (2005) NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS Drug Rev 11:353\u2013368","journal-title":"CNS Drug Rev"},{"key":"103_CR17","first-page":"493670","volume":"2012","author":"A Idan-Feldman","year":"2012","unstructured":"Idan-Feldman A, Ostritsky R, Gozes I (2012) Tau and caspase 3 as targets for neuroprotection. Int J Alzheimers Dis 2012:493670","journal-title":"Int J Alzheimers Dis"},{"key":"103_CR18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/npp.2013.23","volume":"38","author":"LF Jarskog","year":"2013","unstructured":"Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS, Barch DM, Buchanan RW, Csernansky JG, Goff DC, Harms MP, Javitt DC, Keefe RS, McEvoy JP, McMahon RP, Marder SR, Peterson BS, Lieberman JA (2013) Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology 38:1245\u20131252","journal-title":"Neuropsychopharmacology"},{"key":"103_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2011.11.001","volume":"136","author":"DC Javitt","year":"2012","unstructured":"Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, Barch DS, Ball MP, Robinson J, Marder SR (2012) Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res 136:25\u201331","journal-title":"Schizophr Res"},{"key":"103_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2013.04.012","volume":"56C","author":"Y Jouroukhin","year":"2013","unstructured":"Jouroukhin Y, Ostritsky R, Assaf Y, Pelled G, Giladi E, Gozes I (2013) NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport. Neurobiol Dis 56C:79\u201394","journal-title":"Neurobiol Dis"},{"key":"103_CR21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12031-012-9882-6","volume":"48","author":"Y Jouroukhin","year":"2012","unstructured":"Jouroukhin Y, Ostritsky R, Gozes I (2012) d-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy. J Mol Neurosci 48:597\u2013602","journal-title":"J Mol Neurosci"},{"key":"103_CR22","first-page":"49","volume":"83","author":"RR Leker","year":"2002","unstructured":"Leker RR, Shohami E, Constantini S (2002) Experimental models of head trauma. Acta Neurochir Suppl 83:49\u201354","journal-title":"Acta Neurochir Suppl"},{"key":"103_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/JMN\/31:02:165","volume":"31","author":"Y Matsuoka","year":"2007","unstructured":"Matsuoka Y, Gray AJ, Hirata-Fukae C, Minami SS, Waterhouse EG, Mattson MP, LaFerla FM, Gozes I, Aisen PS (2007) Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer\u2019s disease at early pathological stage. J Mol Neurosci 31:165\u2013170","journal-title":"J Mol Neurosci"},{"key":"103_CR24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","volume":"325","author":"Y Matsuoka","year":"2008","unstructured":"Matsuoka Y, Jouroukhin Y, Gray AJ, Ma L, Hirata-Fukae C, Li HF, Feng L, Lecanu L, Walker BR, Planel E, Arancio O, Gozes I, Aisen PS (2008) A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer\u2019s disease. J Pharmacol Exp Ther 325:146\u2013153","journal-title":"J Pharmacol Exp Ther"},{"key":"103_CR25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.peptides.2010.04.011","volume":"31","author":"A Merenlender-Wagner","year":"2010","unstructured":"Merenlender-Wagner A, Pikman R, Giladi E, Andrieux A, Gozes I (2010) NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse\u2014a microtubule-deficient model of schizophrenia. Peptides 31:1368\u20131373","journal-title":"Peptides"},{"key":"103_CR26","first-page":"16","volume":"27","author":"BH Morimoto","year":"2009","unstructured":"Morimoto BH, de Lannoy I, Fox AW, Gozes I, Stewart AJ (2009) Davunetide: pharmacokinetics and distribution to brain after intravenous or intranasal administration to rat. Chimica Oggi\/Chemistry Today 27:16\u201320","journal-title":"Chimica Oggi\/Chemistry Today"},{"key":"103_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47\u201360","journal-title":"J Neurosci Methods"},{"key":"103_CR28","doi-asserted-by":"crossref","first-page":"e51458","DOI":"10.1371\/journal.pone.0051458","volume":"7","author":"S Oz","year":"2012","unstructured":"Oz S, Ivashko-Pachima Y, Gozes I (2012) The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities. PLoS One 7:e51458","journal-title":"PLoS One"},{"key":"103_CR29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1471-4159.2007.04834.x","volume":"103","author":"M Perez","year":"2007","unstructured":"Perez M, Santa-Maria I, Tortosa E, Cuadros R, Del Valle M, Hernandez F, Moreno FJ, Avila J (2007) The role of the VQIVYK peptide in tau protein phosphorylation. J Neurochem 103:1447\u20131460","journal-title":"J Neurochem"},{"key":"103_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-3806(03)00162-7","volume":"144","author":"A Pinhasov","year":"2003","unstructured":"Pinhasov A, Mandel S, Torchinsky A, Giladi E, Pittel Z, Goldsweig AM, Servoss SJ, Brenneman DE, Gozes I (2003) Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res Dev Brain Res 144:83\u201390","journal-title":"Brain Res Dev Brain Res"},{"key":"103_CR31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/mp.2013.32","volume":"18","author":"S Quraishe","year":"2013","unstructured":"Quraishe S, Cowan CM, Mudher A (2013) NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy. Mol Psychiatry 18:834\u2013842","journal-title":"Mol Psychiatry"},{"key":"103_CR32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2009.02.011","volume":"34","author":"N Shiryaev","year":"2009","unstructured":"Shiryaev N, Jouroukhin Y, Giladi E, Polyzoidou E, Grigoriadis NC, Rosenmann H, Gozes I (2009) NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model. Neurobiol Dis 34:381\u2013388","journal-title":"Neurobiol Dis"},{"key":"103_CR33","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2174\/138161211797416093","volume":"17","author":"N Shiryaev","year":"2011","unstructured":"Shiryaev N, Pikman R, Giladi E, Gozes I (2011) Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects. Curr Pharm Des 17:2603\u20132612","journal-title":"Curr Pharm Des"},{"key":"103_CR34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/ddq521","volume":"20","author":"H Sudo","year":"2011","unstructured":"Sudo H, Baas PW (2011) Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases. Hum Mol Genet 20:763\u2013778","journal-title":"Hum Mol Genet"},{"key":"103_CR35","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","volume":"97","author":"M Bergen von","year":"2000","unstructured":"von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A 97:5129\u20135134","journal-title":"Proc Natl Acad Sci U S A"},{"key":"103_CR36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.107.129551","volume":"323","author":"I Vulih-Shultzman","year":"2007","unstructured":"Vulih-Shultzman I, Pinhasov A, Mandel S, Grigoriadis N, Touloumi O, Pittel Z, Gozes I (2007) Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J Pharmacol Exp Ther 323:438\u2013449","journal-title":"J Pharmacol Exp Ther"},{"key":"103_CR37","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1073\/pnas.1331636100","volume":"100","author":"MF Wilkemeyer","year":"2003","unstructured":"Wilkemeyer MF, Chen SY, Menkari CE, Brenneman DE, Sulik KK, Charness ME (2003) Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity. Proc Natl Acad Sci U S A 100:8543\u20138548","journal-title":"Proc Natl Acad Sci U S A"},{"key":"103_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-0115(00)00198-1","volume":"96","author":"I Zemlyak","year":"2000","unstructured":"Zemlyak I, Furman S, Brenneman DE, Gozes I (2000) A novel peptide prevents death in enriched neuronal cultures. Regul Pept 96:39\u201343","journal-title":"Regul Pept"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-0103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-013-0103-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-0103-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:08:12Z","timestamp":1715969292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-013-0103-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1007\/s12031-013-0103-8","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,10]]}}}